Performance of Binax NOW Flu A and B and direct fluorescent assay in comparison with a composite of viral culture or reverse transcription polymerase chain reaction for detection of influenza infection during the 2006 to 2007 season

Mahbubur Rahman; Mary F. Vandermause; Burney A. Kieke; Edward A. Belongia

doi:10.1016/j.diagmicrobio.2007.10.012

Performance of Binax NOW Flu A and B and direct fluorescent assay in comparison with a composite of viral culture or reverse transcription polymerase chain reaction for detection of influenza infection during the 2006 to 2007 season

Mahbubur Rahman, Mary F. Vandermause, Burney A. Kieke, Edward A. Belongia

Research output: Contribution to journal › Article › peer-review

40 Scopus citations

Abstract

The Binax NOW Flu A and Flu B (Binax NOW), direct fluorescent assay (DFA), and viral culture were evaluated and compared with a composite of viral culture or reverse transcription polymerase chain reaction (RT-PCR). Participants with medically attended acute respiratory illness were identified through active surveillance during the 2006 to 2007 season, and consenting individuals (n = 932) were tested for influenza by culture and RT-PCR. Physicians ordered a rapid antigen test (Binax NOW [n = 73] or DFA [n = 70]) according to their clinical judgment. The Binax NOW detected 11 of 18 influenza infections (sensitivity, 61%; 95% confidence interval [CI], 36-83%), whereas DFA detected 17 of 21 influenza infections (sensitivity 81%, 95% CI, 58-95%). Compared with culture/RT-PCR, specificity of both Binax NOW and DFA was 100%. During the 2006 to 2007 influenza season, DFA and Binax NOW demonstrated high specificity but failed to identify a substantial proportion of influenza infections.

Original language	English (US)
Pages (from-to)	162-166
Number of pages	5
Journal	Diagnostic Microbiology and Infectious Disease
Volume	62
Issue number	2
DOIs	https://doi.org/10.1016/j.diagmicrobio.2007.10.012
State	Published - Oct 2008

Keywords

Binax NOW
Direct fluorescent assay
Influenza virus
Rapid test
Sensitivity
Specificity

ASJC Scopus subject areas

Microbiology (medical)
Infectious Diseases

Access to Document

10.1016/j.diagmicrobio.2007.10.012

Fingerprint

Dive into the research topics of 'Performance of Binax NOW Flu A and B and direct fluorescent assay in comparison with a composite of viral culture or reverse transcription polymerase chain reaction for detection of influenza infection during the 2006 to 2007 season'. Together they form a unique fingerprint.

Cite this

Rahman, M., Vandermause, M. F., Kieke, B. A., & Belongia, E. A. (2008). Performance of Binax NOW Flu A and B and direct fluorescent assay in comparison with a composite of viral culture or reverse transcription polymerase chain reaction for detection of influenza infection during the 2006 to 2007 season. Diagnostic Microbiology and Infectious Disease, 62(2), 162-166. https://doi.org/10.1016/j.diagmicrobio.2007.10.012

Performance of Binax NOW Flu A and B and direct fluorescent assay in comparison with a composite of viral culture or reverse transcription polymerase chain reaction for detection of influenza infection during the 2006 to 2007 season. / Rahman, Mahbubur; Vandermause, Mary F.; Kieke, Burney A. et al.
In: Diagnostic Microbiology and Infectious Disease, Vol. 62, No. 2, 10.2008, p. 162-166.

Research output: Contribution to journal › Article › peer-review

Rahman, M, Vandermause, MF, Kieke, BA & Belongia, EA 2008, 'Performance of Binax NOW Flu A and B and direct fluorescent assay in comparison with a composite of viral culture or reverse transcription polymerase chain reaction for detection of influenza infection during the 2006 to 2007 season', Diagnostic Microbiology and Infectious Disease, vol. 62, no. 2, pp. 162-166. https://doi.org/10.1016/j.diagmicrobio.2007.10.012

Rahman M, Vandermause MF, Kieke BA, Belongia EA. Performance of Binax NOW Flu A and B and direct fluorescent assay in comparison with a composite of viral culture or reverse transcription polymerase chain reaction for detection of influenza infection during the 2006 to 2007 season. Diagnostic Microbiology and Infectious Disease. 2008 Oct;62(2):162-166. doi: 10.1016/j.diagmicrobio.2007.10.012

Rahman, Mahbubur ; Vandermause, Mary F. ; Kieke, Burney A. et al. / Performance of Binax NOW Flu A and B and direct fluorescent assay in comparison with a composite of viral culture or reverse transcription polymerase chain reaction for detection of influenza infection during the 2006 to 2007 season. In: Diagnostic Microbiology and Infectious Disease. 2008 ; Vol. 62, No. 2. pp. 162-166.

@article{b2694b02b4b44020ab86e715675f02db,

title = "Performance of Binax NOW Flu A and B and direct fluorescent assay in comparison with a composite of viral culture or reverse transcription polymerase chain reaction for detection of influenza infection during the 2006 to 2007 season",

abstract = "The Binax NOW Flu A and Flu B (Binax NOW), direct fluorescent assay (DFA), and viral culture were evaluated and compared with a composite of viral culture or reverse transcription polymerase chain reaction (RT-PCR). Participants with medically attended acute respiratory illness were identified through active surveillance during the 2006 to 2007 season, and consenting individuals (n = 932) were tested for influenza by culture and RT-PCR. Physicians ordered a rapid antigen test (Binax NOW [n = 73] or DFA [n = 70]) according to their clinical judgment. The Binax NOW detected 11 of 18 influenza infections (sensitivity, 61%; 95% confidence interval [CI], 36-83%), whereas DFA detected 17 of 21 influenza infections (sensitivity 81%, 95% CI, 58-95%). Compared with culture/RT-PCR, specificity of both Binax NOW and DFA was 100%. During the 2006 to 2007 influenza season, DFA and Binax NOW demonstrated high specificity but failed to identify a substantial proportion of influenza infections.",

keywords = "Binax NOW, Direct fluorescent assay, Influenza virus, Rapid test, Sensitivity, Specificity",

author = "Mahbubur Rahman and Vandermause, {Mary F.} and Kieke, {Burney A.} and Belongia, {Edward A.}",

year = "2008",

month = oct,

doi = "10.1016/j.diagmicrobio.2007.10.012",

language = "English (US)",

volume = "62",

pages = "162--166",

journal = "Diagnostic Microbiology and Infectious Disease",

issn = "0732-8893",

publisher = "Elsevier Inc.",

number = "2",

}

TY - JOUR

T1 - Performance of Binax NOW Flu A and B and direct fluorescent assay in comparison with a composite of viral culture or reverse transcription polymerase chain reaction for detection of influenza infection during the 2006 to 2007 season

AU - Rahman, Mahbubur

AU - Vandermause, Mary F.

AU - Kieke, Burney A.

AU - Belongia, Edward A.

PY - 2008/10

Y1 - 2008/10

N2 - The Binax NOW Flu A and Flu B (Binax NOW), direct fluorescent assay (DFA), and viral culture were evaluated and compared with a composite of viral culture or reverse transcription polymerase chain reaction (RT-PCR). Participants with medically attended acute respiratory illness were identified through active surveillance during the 2006 to 2007 season, and consenting individuals (n = 932) were tested for influenza by culture and RT-PCR. Physicians ordered a rapid antigen test (Binax NOW [n = 73] or DFA [n = 70]) according to their clinical judgment. The Binax NOW detected 11 of 18 influenza infections (sensitivity, 61%; 95% confidence interval [CI], 36-83%), whereas DFA detected 17 of 21 influenza infections (sensitivity 81%, 95% CI, 58-95%). Compared with culture/RT-PCR, specificity of both Binax NOW and DFA was 100%. During the 2006 to 2007 influenza season, DFA and Binax NOW demonstrated high specificity but failed to identify a substantial proportion of influenza infections.

AB - The Binax NOW Flu A and Flu B (Binax NOW), direct fluorescent assay (DFA), and viral culture were evaluated and compared with a composite of viral culture or reverse transcription polymerase chain reaction (RT-PCR). Participants with medically attended acute respiratory illness were identified through active surveillance during the 2006 to 2007 season, and consenting individuals (n = 932) were tested for influenza by culture and RT-PCR. Physicians ordered a rapid antigen test (Binax NOW [n = 73] or DFA [n = 70]) according to their clinical judgment. The Binax NOW detected 11 of 18 influenza infections (sensitivity, 61%; 95% confidence interval [CI], 36-83%), whereas DFA detected 17 of 21 influenza infections (sensitivity 81%, 95% CI, 58-95%). Compared with culture/RT-PCR, specificity of both Binax NOW and DFA was 100%. During the 2006 to 2007 influenza season, DFA and Binax NOW demonstrated high specificity but failed to identify a substantial proportion of influenza infections.

KW - Binax NOW

KW - Direct fluorescent assay

KW - Influenza virus

KW - Rapid test

KW - Sensitivity

KW - Specificity

UR - http://www.scopus.com/inward/record.url?scp=51649115039&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=51649115039&partnerID=8YFLogxK

U2 - 10.1016/j.diagmicrobio.2007.10.012

DO - 10.1016/j.diagmicrobio.2007.10.012

M3 - Article

C2 - 18060723

AN - SCOPUS:51649115039

SN - 0732-8893

VL - 62

SP - 162

EP - 166

JO - Diagnostic Microbiology and Infectious Disease

JF - Diagnostic Microbiology and Infectious Disease

IS - 2

ER -

Performance of Binax NOW Flu A and B and direct fluorescent assay in comparison with a composite of viral culture or reverse transcription polymerase chain reaction for detection of influenza infection during the 2006 to 2007 season

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this